Bicocca Open Archive

Logo unimib boa
ROMERIO, ALESSIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.679
AS - Asia 2.314
NA - Nord America 1.686
SA - Sud America 264
AF - Africa 52
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.023
Salva come PNG Salva come JPEG
Nazione #
SE - Svezia 3.756
US - Stati Uniti d'America 1.588
IT - Italia 930
VN - Vietnam 559
SG - Singapore 558
CN - Cina 375
DE - Germania 298
HK - Hong Kong 211
BR - Brasile 190
RU - Federazione Russa 173
IN - India 133
KR - Corea 95
FR - Francia 85
GB - Regno Unito 84
BD - Bangladesh 72
NL - Olanda 63
CA - Canada 61
JP - Giappone 56
ID - Indonesia 54
ES - Italia 51
IE - Irlanda 42
PL - Polonia 42
FI - Finlandia 34
PK - Pakistan 31
AR - Argentina 26
AU - Australia 26
IR - Iran 26
MX - Messico 23
BE - Belgio 22
IQ - Iraq 22
TR - Turchia 20
ZA - Sudafrica 20
DK - Danimarca 17
AT - Austria 14
UA - Ucraina 14
MY - Malesia 12
PH - Filippine 12
CO - Colombia 11
CL - Cile 10
EC - Ecuador 10
LT - Lituania 10
SA - Arabia Saudita 10
UZ - Uzbekistan 10
CH - Svizzera 9
MA - Marocco 8
PT - Portogallo 8
TW - Taiwan 8
IL - Israele 7
PY - Paraguay 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
GR - Grecia 5
JO - Giordania 5
AL - Albania 4
EG - Egitto 4
ET - Etiopia 4
KZ - Kazakistan 4
LB - Libano 4
NG - Nigeria 4
NP - Nepal 4
CR - Costa Rica 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
GA - Gabon 3
JM - Giamaica 3
TN - Tunisia 3
AM - Armenia 2
BB - Barbados 2
KE - Kenya 2
KH - Cambogia 2
MK - Macedonia 2
NO - Norvegia 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
RO - Romania 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
A1 - Anonimo 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DZ - Algeria 1
GE - Georgia 1
GY - Guiana 1
HU - Ungheria 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
Totale 10.020
Salva come PNG Salva come JPEG
Città #
Stockholm 3.726
Milan 338
Singapore 335
Frankfurt am Main 252
San Jose 208
Ashburn 199
Ho Chi Minh City 184
Hong Kong 182
Hanoi 131
Los Angeles 92
Ann Arbor 90
Hefei 70
New York 57
Beijing 53
Rome 50
Seoul 50
Dallas 48
Council Bluffs 47
Jakarta 43
Dublin 42
Chicago 39
Tokyo 39
Boardman 36
Santa Clara 35
São Paulo 32
Toronto 29
Amsterdam 28
Chandler 28
Jeju City 27
Turin 27
Buffalo 26
Florence 22
Hyderabad 22
Shanghai 22
Helsinki 21
Bologna 20
Maastricht 20
London 19
Brisbane 18
Houston 18
Warsaw 17
Can Tho 16
Naples 16
Da Nang 15
Lauterbourg 15
Madison 15
New Delhi 15
Orem 15
The Dalles 15
Atlanta 14
Chennai 14
Montreal 14
Paris 14
Copenhagen 13
Ha Long 13
Johannesburg 13
Sassuolo 13
Biên Hòa 12
Columbus 12
Denver 12
Monza 12
San Giuliano Terme 12
Boston 11
Brescia 11
Haiphong 11
Moscow 11
Baghdad 10
Brooklyn 10
Hải Dương 10
Philadelphia 10
Poplar 10
Tashkent 10
Kent 9
Lahore 9
Lappeenranta 9
Nuremberg 9
Vienna 9
Austin 8
Brussels 8
Cerdanyola del Vallès 8
Como 8
Desio 8
Mexico City 8
Munich 8
Princeton 8
Quận Bình Thạnh 8
San Francisco 8
Barnet 7
Cedar Rapids 7
Guangzhou 7
Hangzhou 7
Huế 7
Istanbul 7
Karachi 7
Krakow 7
Medellín 7
Rometta 7
Seattle 7
Sorbolo 7
Vũng Tàu 7
Totale 7.352
Salva come PNG Salva come JPEG
Nome #
Representative secondary PET micro and nanoplastics via ethylene glycol fragmentation (EGF): Physicochemical and immuno-toxicological properties 1.951
Validating Natural Compounds as Toll-Like Receptor 4 (TLR4) Antagonists: Experimental Challenges and Therapeutic Perspectives 1.926
Synthesis and Biological Characterization of TLR4 Agonists as Innovative Vaccine Adjuvants 803
NEW SYNTHETIC AGONISTS OF TLR4 RECEPTOR 494
Vibrational spectroscopy coupled with machine learning sheds light on the cellular effects induced by rationally designed TLR4 agonists 391
Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart Failure 367
Synthetic Glycolipids as Molecular Vaccine Adjuvants: Mechanism of Action in Human Cells and in Vivo Activity 336
Potentiation of fluoroquinolone and macrolide activities by efflux pump inhibitory effect on Staphylococcus aureus and Streptococcus pyogenes of new benzyl piperazinyl lysine derivatives 324
Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators: An Overview 324
New Glucosamine-Based TLR4 Agonists: Design, Synthesis, Mechanism of Action, and In Vivo Activity as Vaccine Adjuvants 290
Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases 287
Impact of Toll-like Receptor 4 (TLR4) chemical modulation by small- molecular antagonists in rare inflammatory-fibrotic diseases 271
Design, Synthesis and characterization of synthetic and natural derived TLR4 antagonists 264
Towards more efficient synthetic immunomodulators: biological characterization and mechanism of action of monosaccharide-derived TLR4 agonists 256
Novel TLR4-Activating Vaccine Adjuvant Enhances the Production of Enterococcus faecium-binding Antibodies 244
Development of a New Vaccine Adjuvant System Based on the Combination of the Synthetic TLR4 Agonist FP20 and a Synthetic QS-21 Variant 224
Overcoming Challenges in Chemical Glycosylation to Achieve Innovative Vaccine Adjuvants Possessing Enhanced TLR4 Activity 223
Cleaner synthesis of preclinically validated vaccine adjuvants 179
Preclinical development of the TLR4 antagonist FP12 as a drug lead targeting the HMGB1/MD-2/TLR4 axis in lethal influenza infection 162
Monosaccharide-Based Synthetic TLR4 Agonist Enhances Vaccine Efficacy against Pseudomonas aeruginosa Challenge 157
Functional impact of Toll-like Receptor 4 (TLR4) modulation in lung fibrosis-associated fibroblasts 128
Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases 127
Developing New Toll-Like Receptor 4 (TLR4) Modulators As Innovative And Inexpensive Vaccine Adjuvants 69
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW, GLYCOLIPID-BASED TOLL-LIKE RECEPTOR 4 (TLR4) MODULATORS 52
Developing New Toll-Like Receptor 4 (TLR4) Modulators as Innovative and Inexpensive Vaccine Adjuvants 51
Design, synthesis and Biological evaluation of New, glycolipid-based Toll-Like Receptor 4 (TLR4) Modulators 44
Design, synthesis and Biological evaluation of New, glycolipid-based Toll-Like Receptor 4 (TLR4) Modulators 40
Design, Synthesis and Biological Evaluation of New Glycolipid-Based Toll-Like Receptor 4 (TLR4) Modulators 40
Design, synthesis and Biological evaluation of New, glycolipid-based Toll-Like Receptor 4 (TLR4) Modulators 39
NEW SMALL MOLECULES AS TLR4 MODULATORS: SYNTHESIS AND BIOLOGICAL CHARACTERIZATION 36
Design, synthesis and Biological evaluation of New, glycolipid-based Toll-Like Receptor 4 (TLR4) Modulators 35
Totale 10.134
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.815
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.815
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022118 0 0 0 0 0 0 0 28 14 12 16 48
2022/2023501 43 58 42 35 51 50 12 88 21 42 26 33
2023/2024536 52 19 39 31 52 65 44 23 53 42 42 74
2024/20251.451 70 89 120 101 104 76 77 64 131 194 148 277
2025/20267.528 557 251 225 404 320 164 392 184 346 4.197 155 333
Totale 10.134